These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 37543771)

  • 1. Bioinformatic analysis the expression and clinical significance of CDRT15 in cholangiocarcinoma using TCGA database.
    Yu T; Zhang T; Zhao L; Li K; Li J; Yu A
    Medicine (Baltimore); 2023 Aug; 102(31):e34602. PubMed ID: 37543771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of TPD52 and DNAJB1 as two novel bile biomarkers for cholangiocarcinoma by iTRAQ‑based quantitative proteomics analysis.
    Ren H; Luo M; Chen J; Zhou Y; Li X; Zhan Y; Shen D; Chen B
    Oncol Rep; 2019 Dec; 42(6):2622-2634. PubMed ID: 31661142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a prognosis-related ceRNA network in cholangiocarcinoma and potentially therapeutic molecules using a bioinformatic approach and molecular docking.
    Gao X; Zhang W; Jia Y; Xu H; Zhu Y; Pei X
    Sci Rep; 2022 Sep; 12(1):16247. PubMed ID: 36171401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expressional and prognostic value of HPCAL1 in cholangiocarcinoma via integrated bioinformatics analyses and experiments.
    Ma M; Zeng G; Li J; Liang J; Huang L; Chen J; Lai J
    Cancer Med; 2023 Jan; 12(1):824-836. PubMed ID: 35645147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a prediction model for postoperative prognosis in patients with resectable cholangiocarcinoma based on silence information regulator 2 expression.
    Wang W; Ji W; Lyu Z; Sun W; Shao Y; Liu J; Yang Y
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 53(1):98-107. PubMed ID: 38105682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
    Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
    Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHST4 might promote the malignancy of cholangiocarcinoma.
    Zhang G; Liu X; Jian A; Zheng K; Wang H; Hao J; Zhi S; Zhang X
    PLoS One; 2022; 17(3):e0265069. PubMed ID: 35294478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated pan-cancer analysis of centromere protein F and experimental verification of its role and clinical significance in cholangiocarcinoma.
    Cao Z; Zeng L; Wang Z; Wen X; Zhang J
    Funct Integr Genomics; 2023 May; 23(2):190. PubMed ID: 37247093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional profiles of peripheral blood leukocytes identify patients with cholangiocarcinoma and predict outcome.
    Subimerb C; Wongkham C; Khuntikeo N; Leelayuwat C; McGrath MS; Wongkham S
    Asian Pac J Cancer Prev; 2014; 15(10):4217-24. PubMed ID: 24935374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YKL-40/chitinase-3-like protein 1 is associated with poor prognosis and promotes cell growth and migration of cholangiocarcinoma.
    Thongsom S; Chaocharoen W; Silsirivanit A; Wongkham S; Sripa B; Choe H; Suginta W; Talabnin C
    Tumour Biol; 2016 Jul; 37(7):9451-63. PubMed ID: 26781979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
    Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
    Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
    Gene; 2019 May; 698():50-60. PubMed ID: 30822475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Prognostic Role of SOCS3 and A20 in Human Cholangiocarcinoma.
    Wang Y; Wan M; Zhou Q; Wang H; Wang Z; Zhong X; Zhang L; Tai S; Cui Y
    PLoS One; 2015; 10(10):e0141165. PubMed ID: 26485275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and Validation of Novel Biomarkers and Potential Targeted Drugs in Cholangiocarcinoma: Bioinformatics, Virtual Screening, and Biological Evaluation.
    Wang J; Zhu W; Tu J; Zheng Y
    J Microbiol Biotechnol; 2022 Oct; 32(10):1262-1274. PubMed ID: 36224755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
    Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
    Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of protein tyrosine phosphatase receptor S (PTPRS) is an independent prognostic marker for cholangiocarcinoma.
    Lertpanprom M; Silsirivanit A; Tippayawat P; Proungvitaya T; Roytrakul S; Proungvitaya S
    Front Public Health; 2022; 10():835914. PubMed ID: 35991009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
    Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
    Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dense GM-CSFR
    Saranaruk P; Waraasawapati S; Chamgramol Y; Sawanyawisuth K; Paungpan N; Somphud N; Wongkham C; Okada S; Wongkham S; Vaeteewoottacharn K
    PeerJ; 2023; 11():e14883. PubMed ID: 36883059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma.
    Boonjaraspinyo S; Boonmars T; Wu Z; Loilome W; Sithithaworn P; Nagano I; Pinlaor S; Yongvanit P; Nielsen PS; Pairojkul C; Khuntikeo N
    Tumour Biol; 2012 Oct; 33(5):1785-802. PubMed ID: 22733151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.